PGM2L1 and synovial sarcoma: Collectively, TOX, DNM3, KLHL42, PGM2L1, and SESN3 might be a common gene expression signature in malignant CD4+ T cells from advanced-stage MF/SS, and could be developed as markers for its diagnosis and prognosis.